Stock Ticker

  • Loading stock data...

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Unveils Positive Results From Phase 2A Clinical Trial For Dry Eye Disease

Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced recently the positive results from its Phase 2a clinical trial of topical ocular (ADX-102) for treatment of patients with a dry eye condition. The ADX-102 is a potential agent that treats dry eye disease, a complex medical condition affecting about 20 million people in the US. The disease causes discomfort, […]

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Stock Falls After HCV Agreement With Johnson & Johnson (NYSE:JNJ) Ends

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares dropped 20% lower at the beginning of the week immediately after announcing that its hepatitis C partnership with Johnson & Johnson (NYSE:JNJ) pharmaceutical unit has ended. The two companies were jointly developing hepatitis treatments (JNJ-4178) for people suffering from hepatitis C. Achillion reported that it received a notice from its […]

Antares Pharma Inc (NASDAQ:ATRS) Announces Positive Phase III Trials That Support Xyosted Approval

Antares Pharma Inc (NASDAQ:ATRS) announced recently the positive Phase III trials that may support the approval of Xyosted , which was initially known as the Quickshot Testosterone. The approval date for Xyosted by the FDA is on October 20 and the company is optimistic that the approval for the drug will be guaranteed without major […]

Argos Therapeutics Inc (NASDAQ:ARGS) Pronounces The Initial Dosing Of HIV Patient With New Therapy

The stock of Argos Therapeutics Inc (NASDAQ:ARGS) closed at $0.20 losing 3.85% in yesterday’s trading session. This provider today made a report outlining that for the first time a patient in the ongoing Phase 2 HIV eradication trial was dosed with AGS-004 dendritic cell therapy. It was developed utilizing RNA antigens from the patient’s latent viral […]

ImmunoGen, Inc. (NASDAQ:IMGN) and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) Collaborates To Build ADC Molecule

ImmunoGen, Inc. (NASDAQ:IMGN) announced recently that they are entering into a partnership and option agreement with Jazz Pharmaceuticals plc –Ordinary Shares (NASDAQ:JAZZ) to develop and commercialize the stage two, hematology-related Antibody-Drug Conjugate (ADC) programs in addition to another program that will be authorized within the terms of agreement. The programs will cover the IMGN779- CD33-targeting […]

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Announces FOTIVDA® Licensed In EU For Cure Of Advanced Renal Cell Carcinoma

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced recently that the European Commission (EC) has approved FOTIVDA® (tivozanib) to be used for the treatment of adults who are diagnosed with the Advanced Renal Cell Carcinoma (RCC) within the European Union (EU), together with Norway, and Iceland regions. Tivozanib is specified for adult patients suffering from the advanced RCC […]

OpenText (USA) (NASDAQ:OTEX) Gets Guidance Software, Inc. (NASDAQ:GUID) For $222 Million

OpenText (USA) (NASDAQ:OTEX) has announced its plans to purchase the Guidance Software, Inc. (NASDAQ:GUID), the company that makes the forensic software for close to $222 million. The Guidance software is recognized for its digital invention and its endpoint information on security outcomes. The Ontario-based company wants to use the new deal to reinforce its entire […]

Moleculin Biotech Inc. (NASDAQ:MBRX) Could Benefit More Than Anticipated From The Agreement with MD Anderson on Leukemia Drug, Annamycin

Latest sources have revealed the fact that Moleculin Biotech Inc. (NASDAQ:MBRX) has finally signed an agreement with MD Anderson Cancer Center. The follows their deal which involved the Leukemia Drug called Annamycin. The signing of this agreement had some underlying deals which includes licensing agreement. Apparently, Moleculin is signing a new technology agreement with MD […]

Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries

Amgen, Inc. (NASDAQ:AMGN) and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune diseases. The unrevealed target and lead inhibitors were found out through the Array’s proprietary podium that leverages its capability in chemistry and early development. Array Biopharma made a deal with […]

Is Petlife Pharmaceuticals Inc (PTLF) a Real Opportunity Right Now?

Petlife Pharmaceuticals Inc (OTCMKTS:PTLF) is an interesting name in the biotechnology and animal life sciences space that may deserve a closer look for investors in search of speculative targets in the small and microcap markets. There’s a lot going on here, but the stock has been sorely underappreciated by investors, possibly creating a deep discount/value […]

Applied DNA Sciences Inc (NASDAQ:APDN) Gets Into A Licensing Agreement With Himatsingka America

Applied DNA Sciences Inc (NASDAQ:APDN) had some time back dropped a hint about it signing into a new licensing agreement with Himatsingka America, Inc. The latest news about it keeping its promise has excited a lot of the concerned parties. They see it as a major step forward towards the company thriving in business. That […]

The Corporate Responsibility Magazine Ranks Xerox Corp (NYSE:XRX) In The “100 Best Corporate Citizens List”

Xerox Corp (NYSE:XRX) has received recognition from the Corporate Responsibility (CR) Magazine, which is widely known for making analysis of best practices as well as nurturing a greener world. As a matter of fact, the top end company deserves this recognition considering the great efforts it has directed towards establishing programs that support a greener world. […]

Glu Mobile Inc (NASDAQ:GLUU) Extends Partnership With Gordon Ramsay As It Proceeds To Unveil A Major Update

Glu Mobile Inc (NASDAQ:GLUU), which happens to one of the industry leaders when it comes to developing and publishing the free-to-play mobile games has today moved forward to make the much awaited announcement. The top end provider broke the news today and it sparked a great wave of excitement across the divide after the concerned […]

The Filing Of 510(K) For Microcutter 5/80™ Expanded Indications By Dextera Surgical Inc (NASDAQ:DXTR) To Help Treat Critical Health Complications

Dextera Surgical Inc (NASDAQ:DXTR), which happens to be one of the trusted and renowned providers in the development as well as the commercialization of the MicroCutter 5/80™ stapler has today made the much awaited news. The company has announced its move to file a 510(k) with the U.S. Food and Drug Administration for expanded indications […]

SunPower Corporation (NASDAQ:SPWR) Headed Towards Business Prosperity Considering Its Initiation Of The 28 MW Air Force Solar Project

The latest news hitting the airwaves at the moment is about the move by SunPower Corporation (NASDAQ:SPWR) to actually initiate the setting up of a 28 megawatt (MW) solar photovoltaic system which according to sources is at Vandenberg Air Force Base near Lompoc, CA. Before moving ahead to say anything else, it is important to […]

Sign Up To Get Our Latest Stocks Alerts